« Back
Home /
Recombinant Human CXCL14 / BRAK

Recombinant Human CXCL14 / BRAK

Manufacturer	Cell Sciences
Category	Oncology Peptides & Proteins Recombinant Proteins By Organ Breast Cancer
Type	Proteins
Specific against	Human
Amount	20 ug
Host	E.coli
Item no.	CS-CRB504B
eClass 6.1	34160400
eClass 9.0	42020190
Available
Biological Activity	Determined by its ability to chemoattract activated monocytes using a concentration range of 1.0-10.0 ng/ml.
Description	Recombinant human BRAK has 77 amino acids.
Endotoxin Level	< 0.1 ng/ug of BRAK
Formulation	Lyophilized without additives
Molecular Weight	9.4 kDa
Reconstitution	Centrifuge vial prior to opening . First add sterile distilled water to the vial to fully solubilize the protein to a concentration of 0.1-1.0 mg/ml. After complete solubilization of the protein, it can be further diluted to other aqueous solutions.
Storage and Stability	Lyophilized protein is stable for 2 years at -20C and reconstituted protein is stable for 3 months in working aliquots at -20C with a carrier protein. Please note that the addition of any carrier protein into this product may produce unwanted endotoxin. This depends upon the particular application employed. Avoid repeated freeze-thaw cycles .

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.